Metoprolol Succinate Extended Release Tablets

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg

Disponibbli minn:

AFT Pharmaceuticals Ltd

INN (Isem Internazzjonali):

Metoprolol succinate 23.75 mg (equivalent to metoprolol tartrate 25mg)

Dożaġġ:

23.75 mg

Għamla farmaċewtika:

Modified release tablet

Kompożizzjoni:

Active: Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg Excipient: Cellulose acetate Crospovidone Glyceryl monostearate Hypromellose Methacrylic acid copolymer Microcrystalline cellulose Opadry clear YS-1-7006 Opadry white YS-1-7003 Poloxamer 188 Polysorbate 80 Sugar spheres

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

Watson Pharma Private Limited

Indikazzjonijiet terapewtiċi:

Metoprolol Succinate Extended-Release Tablets are indicated for the treatment of: Hypertension - to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Bottle, plastic, HDPE bottle with PP cap - 100 tablets - 36 months from date of manufacture stored at or below 25°C

Data ta 'l-awtorizzazzjoni:

2016-06-24